# Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing

- Link: https://www.thailand-business-news.com/pr-news/novo-holdings-invests-in-foryou-medical-to-support-global-growth-in-advanced-wound-care-manufacturing
- Published: 2026-09-10T14:00:00+07:00
- Author: PR Newswire

SINGAPORE, Sept. 10, 2026 /PRNewswire/ — Novo Holdings, a leading global healthcare
and life sciences investor, today announced a strategic minority investment in Huizhou
ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a China-based contract development
and manufacturing organisation (CDMO) specialising in advanced wound care products.
GL Capital, one of China’s leading healthcare-focused private equity firms, will
remain the company’s majority shareholder.

The investment reflects Novo Holdings’ conviction in the long-term growth of advanced
wound care, increasing global demand for specialised healthcare manufacturing, and
China’s important role in delivering high-quality medical technologies to healthcare
companies around the world.

Headquartered in Huizhou, Guangdong Province, ForYou Medical is a development and
manufacturing partner with a comprehensive portfolio of advanced wound care technologies
and products. Since its founding in 2005, continuous innovation has been at the 
core of the company’s growth, driving the development of an integrated platform 
spanning polymer materials and biomaterial research, product development, regulatory
affairs and large-scale manufacturing. Supported by this innovation ecosystem, together
with deep regulatory expertise and manufacturing excellence, ForYou Medical enables
customers to accelerate innovation across the entire product lifecycle – from concept
development and product registration to commercial production. Today, its advanced
wound care portfolio serves leading healthcare companies across Europe, North America
and Asia.

Advanced wound care is a structurally growing healthcare segment, supported by ageing
populations, increasing prevalence of chronic wounds and continued adoption of advanced
treatment solutions. As healthcare companies increasingly partner with specialist
manufacturers to accelerate innovation, broaden product portfolios and improve operational
efficiency, demand for high-quality CDMO partners continues to grow.

**Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, said:**

"China continues to strengthen its position as a global centre for healthcare innovation
and advanced manufacturing. At Novo Holdings, we are committed to partnering with
exceptional companies that combine strong technological capabilities with international
competitiveness and long-term growth potential. ForYou Medical exemplifies these
qualities, and this investment reflects our confidence in the continued evolution
of China’s life sciences ecosystem."

**Sean He, Partner and Head of China at Novo Holdings, added:**

"ForYou Medical has established itself as a trusted manufacturing partner to many
leading wound care companies through its strong product capabilities, regulatory
expertise and consistent focus on quality. We look forward to working alongside 
the management team and GL Capital to support the company’s continued international
growth, strengthen its innovation capabilities and help expand its global customer
partnerships."

**Zhenfu Li, CEO, GL Capital, said:**

"Since partnering with ForYou Medical, we have worked closely with management to
strengthen the company’s capabilities and accelerate its growth. We are delighted
to welcome Novo Holdings as a like-minded long-term investor whose global healthcare
expertise and international network will further support the company’s next stage
of development."

**Jinwen Mo, CEO, ForYou Medical, said:**

"We are pleased to welcome Novo Holdings as a strategic investor. Their deep experience
across the global healthcare ecosystem, long-term investment approach and international
network make them an excellent partner as we continue expanding our innovation capabilities
and serving customers around the world. Together with GL Capital, we look forward
to building on our strong foundation and creating long-term value for our customers,
employees and partners."

**About ForYou Medical **

Founded in 2005 and headquartered in Huizhou, Guangdong Province, China, ForYou 
Medical is a contract development and manufacturing organisation specialising in
advanced wound care products. The company develops and manufactures a broad portfolio
of advanced wound dressings, haemostatic products and bioabsorbable materials, serving
healthcare companies across major international markets. ForYou Medical combines
advanced manufacturing capabilities with strong regulatory expertise and a continued
focus on product innovation and quality. [https://en.foryoumedical.com/](https://en.foryoumedical.com/)

**About Novo Holdings**

Novo Holdings is a holding and investment company that is responsible for managing
the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings
is to improve people’s health and the sustainability of society and the planet by
generating attractive long-term returns on the assets of the Novo Nordisk Foundation.
Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder
of Novo Nordisk and Novonesis and manages an investment portfolio with a long-term
return perspective. In addition to managing a broad portfolio of equities, bonds,
real estate, infrastructure and private equity assets, Novo Holdings is a world-
leading life sciences investor. As of year-end 2025, Novo Holdings had total assets
of €93 billion. [https://novoholdings.dk/](https://novoholdings.dk/)

**About GL Capital**

GL Capital is an investment firm focusing on controlling-stake projects and growth-
stage enterprises in China’s healthcare industry. Founded in 2010 by Mr. Li Zhenfu,
the former President of Novartis China, the firm manages U.S. dollar-denominated
and RMB-denominated private equity funds as well as hedge funds, with total assets
under management (AUM) exceeding RMB 22 billion.

GL Capital is committed to becoming the most trustworthy partner for leading enterprises
in the industry, continuously delivering excellent returns to its investors, and
jointly promoting the sound development of China’s healthcare industry. As the world’s
second-largest healthcare market, China, driven by factors such as structural reforms,
population aging, and improved medical conditions, provides us with a steady stream
of investment opportunities. GL Capital focuses on investing in outstanding enterprises
with long-term sustainable competitive advantages. We aim to collaborate with like-
minded, visionary management teams to pursue excellence and create value together.

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing ](http://www.prnasia.com/story/archive/5043745_AE43745_0?rand=184833)
